Pharmacovigilance Jobs for Freshers: Roles, Skills, Career

In short: Pharmacovigilance (PV) is the work of detecting, assessing and preventing harm from medicines after they reach patients. Freshers usually start as drug safety associates, handling adverse event reports, literature screening or aggregate report support. This guide is for B.Pharm, M.Pharm, Pharm.D and life-science graduates and explains the roles, key terms, skills, career path and how to avoid fake PV training offers.

What is pharmacovigilance?

The World Health Organization defines pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine- or vaccine-related problem. In plain words: someone has to keep watching a medicine once thousands or millions of people use it, because clinical trials involve limited numbers of patients for limited periods.

A new medicine is tested on a few thousand people at most. Rare side effects, effects in children or elderly patients, and problems from long use may only appear after approval. PV teams collect reports, check whether the medicine could be the cause, and tell regulators, doctors and patients when something new is found.

Pharmacovigilance in India

The Pharmacovigilance Programme of India (PvPI) works under the Ministry of Health and Family Welfare. The Indian Pharmacopoeia Commission (IPC), Ghaziabad, is the National Coordination Centre (NCC) for PvPI. The programme collects adverse drug reaction reports through a network of centres in hospitals and medical institutions, analyses them, and passes its recommendations to the Central Drugs Standard Control Organisation (CDSCO), which takes the regulatory decision.

For companies, IPC has published a Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products in India (Version 2.0, 2024). It says it is guidance and does not replace the rules made under the Drugs and Cosmetics Act, 1940 and Rules, 1945, including the New Drugs and Clinical Trials Rules, 2019 (NDCT Rules). What the IPC guidance says on points that matter to a PV career:

The guidance says serious adverse events must be reported by the marketing authorisation holder to CDSCO and to the NCC-PvPI within 15 calendar days of receipt of the information from any source.
It asks companies to code adverse events and indications, preferably with the latest MedDRA version.
It states that, under the Drugs and Cosmetics Rules including the NDCT Rules, periodic safety update reports (PSURs) for new drugs are submitted every six months for the first two years from approval and annually for the next two years, and that the licensing authority may extend this period.
It expects companies to keep a pharmacovigilance system with written procedures covering case handling, PSUR preparation and signal detection.

Rules and timelines change, so always check the current CDSCO and IPC pages. See also our introduction to clinical trial definitions for the trial-phase vocabulary.

Key terms every PV fresher should know

Term	Plain meaning
Adverse event (AE)	Any unwanted medical occurrence in a patient who took a medicine, whether or not the medicine caused it
Adverse drug reaction (ADR)	A reaction where a causal link with the medicine is at least a reasonable possibility
Serious AE / SAE	An event that, at any dose, results in death, is life-threatening, requires inpatient hospitalisation or prolongs an existing one, results in persistent or significant disability or incapacity, is a congenital anomaly or birth defect, or is an important medical event in medical and scientific judgement
ICSR	Individual Case Safety Report: the report of one suspected reaction in one patient
Expected / unexpected	Whether the reaction is already described in the product’s reference information
PSUR / PBRER	Periodic report on the safety of a marketed product; the ICH E2C(R2) format is the Periodic Benefit-Risk Evaluation Report
Signal	Information from one or more sources suggesting a new potentially causal association, or a new aspect of a known association, between a medicine and an event, judged likely enough to justify checking
MedDRA	The standard medical dictionary used to code events and indications
MAH	Marketing authorisation holder, the company responsible for the product on the market

Definitions of AE, ADR and seriousness are set out in the ICH E2A and E2D(R1) guidelines; the signal definition above follows EMA’s GVP Module IX. Companies may define internal terms differently, so learn the definitions in the procedures of your employer.

Typical entry-level pharmacovigilance roles

Drug safety associate (case processing)

This is the most common first job. You receive a report from a doctor, patient, study or literature source and enter it into a safety database. The steps include checking that the report is valid (an identifiable reporter, an identifiable patient, a suspected medicine and an event), entering the details, coding with MedDRA, assessing seriousness, writing a short narrative, and meeting the submission deadline. Accuracy and speed with discipline matter here.

Literature screening

Teams search medical journals and databases for safety information about their products. You screen articles, flag those that contain case reports or new safety findings and pass them on for processing.

Aggregate report support

After some experience you may help prepare periodic reports such as PSURs or PBRERs. These collect safety data over a period and give an overall benefit-risk view of a product.

Signal detection and risk management

This is usually a step up from the entry role. It involves reviewing data for patterns, discussing them with medical reviewers and updating risk management documents.

Other starting points

Medical information and complaints: answering product queries and logging complaints that may contain safety information. Compare with our guide on handling pharmaceutical market complaints.
Clinical research: safety work in clinical trials, closely related to PV.
Regulatory affairs: product information, labelling and dossiers. See drug regulatory affairs and CTD.

Who hires pharmacovigilance freshers?

Pharmaceutical companies, from large multinationals to Indian manufacturers, with their own drug safety or PV departments.
Contract research organisations (CROs) that run safety work for sponsors during clinical trials.
PV service providers and outsourcing companies, which handle case processing for several clients.
Hospitals and institutions that serve as adverse drug reaction monitoring centres under PvPI, where roles are usually clinical or academic.

We do not recommend or rank any company. Check each employer on its own official website and our fresher jobs listings, and see how a company’s careers page presents the role before applying.

Skills that help you get hired

Medical and pharmacological terminology: know common diseases, organ systems, drug classes and how medicines are used.
Reading and writing clear English: narratives must be short, accurate and consistent with source documents.
Attention to detail: one wrong date or dose can change the meaning of a case.
Basic MedDRA understanding: know what a preferred term is and how coding works. Many employers train this on the job.
Computer skills: comfort with Excel, Word and databases.
Following written procedures and deadlines: safety timelines are strict.
Ethics and confidentiality: patient information is sensitive.

Qualifications commonly asked for

Postings in this field often mention degrees such as B.Pharm, M.Pharm, Pharm.D, B.Sc or M.Sc in life sciences, and sometimes MBBS, BDS or BAMS/BHMS for medical roles. Exact requirements differ between employers, so read the job description rather than relying on a general list. A certificate course is generally an extra, not a substitute for a degree.

A realistic career path

An example progression (titles differ between companies):

Drug safety associate / trainee: case processing, quality checks.
Senior associate: complex cases, mentoring, quality review.
Team lead / aggregate report writer / signal analyst: periodic reports, signal work, client interaction.
Safety scientist or manager: oversight of a product portfolio or team; medical review roles generally need a medical qualification.
Wider options: regulatory affairs, clinical safety, risk management, quality and audit in PV, or medical writing.

Progress depends on your performance, the employer’s needs and the work available. Nobody can promise a timeline.

Protect yourself from fake PV training offers

Because PV is a popular fresher field, it attracts “PV course with 100% placement guarantee” advertisements. Watch out for:

a fee for “registration”, “software access” or “placement”;
a guarantee of a job with a named company;
an offer letter issued before any interview;
recruiters who contact you only via WhatsApp or a free email address.

A real employer does not charge candidates. Read our guide on pharma job scams in India before paying for anything. Training can be useful, but check what is taught, who teaches it and whether it is recognised by employers, without relying on placement claims.

Frequently asked questions

Is pharmacovigilance a good career?

It is a growing field with a clear structure and a real purpose: protecting patients. It suits people who like detail, reading, writing and rules. Work can be repetitive in case-processing roles and deadlines are strict. Whether it is good for you depends on your interest, your employer and the growth path you pick.

What is a PV salary for freshers?

It varies with the company type, city, role and your qualifications, so we do not quote a number. For real examples, look at the salary field in the listings on our jobs board, where an employer states pay in its own notice.

Can a B.Sc or M.Sc graduate work in PV?

Many postings accept life-science graduates for case processing or literature work. Check each posting for its required degree.

Do I need a PV certificate to get a job?

No law requires it. Employers look mainly at your degree, terminology, English and how you do in tests and interviews. A good course can help you prepare, but it is not a guarantee.

Is PV the same as clinical research?

No. They overlap, since safety reporting is part of clinical trials. PV also covers marketed products over their life. Clinical research focuses on running trials.

Is pharmacovigilance work done in shifts or from home?

This depends on the employer and the client. Some teams work in shifts to match global deadlines, and some roles allow home working. Ask at the interview.

References

World Health Organization, Pharmacovigilance (definition), who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance, accessed November 2026.
Indian Pharmacopoeia Commission, Pharmacovigilance Programme of India (PvPI), ipc.gov.in/PvPI/about.html, accessed November 2026.
Indian Pharmacopoeia Commission (NCC-PvPI) with CDSCO, Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products, Version 2.0 (2024), ipc.gov.in and cdsco.gov.in.
ICH E2A, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting (Step 4, 27 October 1994), ich.org.
ICH E2D(R1), Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports (Step 4, 15 September 2025; replaces ICH E2D, Step 4, 12 November 2003), ich.org.
ICH E2C(R2), Periodic Benefit-Risk Evaluation Report (PBRER) (Step 4, November 2012; text dated 17 December 2012), ich.org. See also ema.europa.eu scientific guideline page.
European Medicines Agency, Guideline on good pharmacovigilance practices (GVP) Module IX: Signal management (Rev 1), EMA/827661/2011 Rev 1, in effect from 22 November 2017, ema.europa.eu (definition of signal).